Skip to main content Accessibility help

Insulin gene therapy from design to beta cell generation

  • Ahter D. Sanlioglu (a1) (a2), Hasan Ali Altunbas (a1) (a3), Mustafa Kemal Balci (a1) (a3), Thomas S. Griffith (a4) and Salih Sanlioglu (a1) (a2)...

Despite the fact that insulin injection can protect diabetic patients from developing diabetes-related complications, recent meta-analyses indicate that rapid and long-acting insulin analogues only provide a limited benefit compared with conventional insulin regarding glycemic control. As insulin deficiency is the main sequel of type-1 diabetes (T1D), transfer of the insulin gene-by-gene therapy is becoming an attractive treatment modality even though T1D is not caused by a single genetic defect. In contrast to human insulin and insulin analogues, insulin gene therapy targets to supplement patients not only with insulin but also with C-peptide. So far, insulin gene therapy has had limited success because of delayed and/or transient gene expression. Sustained insulin gene expression is now feasible using current gene-therapy vectors providing patients with basal insulin coverage, but management of postprandial hyperglycaemia is still difficult to accomplish because of the inability to properly control insulin secretion. Enteroendocrine cells of the gastrointestinal track (K cells and L cells) may be ideal targets for insulin gene therapy, but cell-targeting difficulties have limited practical implementation of insulin gene therapy for diabetes treatment. Therefore, recent gene transfer technologies developed to generate authentic beta cells through transdifferentiation are also highlighted in this review.

Corresponding author
*Corresponding author: Salih Sanlioglu VMD, Human Gene and Cell Therapy Center, Akdeniz University Hospitals and Clinics, B Block, 1st Floor, Campus, Antalya, Turkey. Email:
Hide All
1Teuscher, A. (1979) The biological effect of purely synthetic human insulin in patients with diabetes mellitus. Schweizerische Medizinische Wochenschrift 109, 743-747
2Moore, H.P. et al. (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35, 531-538
3Dong, H., Woo, S.L. (2001) Hepatic insulin production for type 1 diabetes. Trends in Endocrinology and Metabolism 12, 441-446
4Wong, M.S., Hawthorne, W.J. and Manolios, N. (2010) Gene therapy in diabetes. Self and Nonself 1, 165-175
5Hughes, A. et al. (2010) Gene therapy to improve pancreatic islet transplantation for Type 1 diabetes mellitus. Current Diabetes Review 6, 274-284
6Bagley, J. et al. (2008) Gene therapy in type 1 diabetes. Critical Reviews in Immunology 28, 301-324
7Nett, P.C., Sollinger, H.W. and Alam, T. (2003) Hepatic insulin gene therapy in insulin-dependent diabetes mellitus. American Journal of Transplantation 3, 1197-1203
8Kobinger, G.P. et al. (2004) Transduction of human islets with pseudotyped lentiviral vectors. Human Gene Therapy 15, 211-219
9Zhang, B. et al. (2001) A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors. Gene Therapy 8, 1745-1751
10Doerschug, K. et al. (2002) First-generation adenovirus vectors shorten survival time in a murine model of sepsis. Journal of Immunol 169, 6539-6545
11Barbu, A.R., Akusjarvi, G. and Welsh, N. (2005) Adenoviral-mediated transduction of human pancreatic islets: importance of adenoviral genome for cell viability and association with a deficient antiviral response. Endocrinology 146, 2406-2414
12Zhang, J.A. et al. (2009) Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD-1 mice. Journal of Gene Medicine 11, 588-597
13Sanlioglu, S. et al. (2001) Rate limiting steps of AAV transduction and implications for human gene therapy. Current Gene Therapy 1, 137-147
14Sanlioglu, S. and Engelhardt, J.F. (1999) Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways. Gene Therapy 6, 1427-1437
15Sanlioglu, S. et al. (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. Journal of Virology 74, 9184-9196
16Sanlioglu, S., Benson, P. and Engelhardt, J.F. (2000) Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 268, 68-78
17Alba, R., Bosch, A. and Chillon, M. (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Therapy 12(Suppl 1), S18-S27
18Palmer, D.J. and Ng, P. (2005) Helper-dependent adenoviral vectors for gene therapy. Human Gene Therapy 16, 1-16
19Kolodka, T.M. et al. (1995) Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proceedings of the National Academy of Sciences of the United States of America 92, 3293-3297
20Falqui, L. et al. (1999) Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Human Gene Therapy 10, 1753-1762
21Auricchio, A. et al. (2002) Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Therapy 9, 963-971
22Vollenweider, F. et al. (1995) Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes 44, 1075-1080
23Groskreutz, D.J., Sliwkowski, M.X. and Gorman, C.M. (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. Journal of Biological Chemistry 269, 6241-6245
24Simonson, G.D. et al. (1996) Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Human Gene Therapy 7, 71-78
25Irminger, J.C., Meyer, K. and Halban, P. (1996) Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochemical Journal 320, 11-15
26Short, D.K. et al. (1998) Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. American Journal of Physiology 275, E748-E756
27Dong, H. et al. (2001) Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Research and Clinical Practice 52, 153-163
28Tanaka, S.I. et al. (2004) Daily nasal inoculation with the insulin gene ameliorates diabetes in mice. Diabetes Research and Clinical Practice 63, 1-9
29Park, Y.M. et al. (2005) Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats. Journal of Gene Medicine 7, 621-629
30Elsner, M. et al. (2012) Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction. Molecular Therapy 20, 918-926
31Lu, D. et al. (1998) Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Therapy 5, 888-895
32Han, J. et al. (2011) Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter. Molecular Therpy 19, 470-478
33Shih, H. and Towle, H.C. (1994) Definition of the carbohydrate response element of the rat S14 gene. Context of the CACGTG motif determines the specificity of carbohydrate regulation. Journal of Biological Chemistry 269, 9380-9387
34Alam, T. and Sollinger, H.W. (2002) Glucose-regulated insulin production in hepatocytes. Transplantation 74, 1781-1787
35Thule, P.M., Liu, J. and Phillips, L.S. (2000) Glucose regulated production of human insulin in rat hepatocytes. Gene Therapy 7, 205-214
36Thule, P.M. et al. (2006) Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats. American Journal of Physiology, Endocrinology and Metabolism 290, E114-E122
37Argaud, D. et al. (1996) Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence. Diabetes 45, 1563-1571
38Chen, R. et al. (2000) Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Therapy 7, 1802-1809
39Chen, R., Meseck, M.L. and Woo, S.L. (2001) Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Molecular Therapy 3, 584-590
40Burkhardt, B.R. et al. (2003) Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells. Annals of the New York Academy of Sciences 1005, 237-241
41Duan, D. et al. (1999) Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. Journal of Virology 73, 161-169
42Sanlioglu, S., Duan, D. and Engelhardt, J.F. (1999) Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Human Gene Therapy 10, 591-602
43Yasutomi, K. et al. (2003) Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus. Biochemical and Biophysical Research Communication 310, 897-903
44Yang, Y.W. and Chao, C.K. (2003) Incorporation of calcium phosphate enhances recombinant adeno-associated virus-mediated gene therapy in diabetic mice. Journal of Gene Medicine 5, 417-424
45Hsu, P.Y. and Yang, Y.W. (2005) Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. Journal of Gene Medicine 7, 1311-1321
46Hsu, P.Y., Kotin, R.M. and Yang, Y.W. (2008) Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharmaceutical Research 25, 1460-1468
47Brockstedt, D.G. et al. (1999) Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clinical Immunology 92, 67-75
48Flotte, T.R. (2004) Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective. Human Gene Therapy 15, 716-717
49Sun, J.Y. et al. (2003) Immune responses to adeno-associated virus and its recombinant vectors. Gene Therapy 10, 964-976
50Rivera, V.M. et al. (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287, 826-830
51Cheung, A.T. et al. (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290, 1959-1962
52Corbett, J.A. (2001) K cells: a novel target for insulin gene therapy for the prevention of diabetes. Trends in Endocrinology and Metabolism 12, 140-142
53Tang, S.C. and Sambanis, A. (2004) Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. Journal of Gene Medicine 6, 1003-1013
54Niu, L. et al. (2008) Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene. World Journal of Gastroenterology 14, 4209-4215
55Halban, P.A. et al. (2001) Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50, 2181-2191
56Wahren, J., Kallas, A. and Sima, A.A. (2012) The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes 61, 761-772
57Kahraman, S. et al. (2011) Tracing of islet graft survival by way of in vivo fluorescence imaging. Diabetes Metabolism Research and Reviews 27, 575-583
58Shapiro, A.M. et al. (2005) Strategic opportunities in clinical islet transplantation. Transplantation 79, 1304-1307
59Collombat, P. et al. (2010) Pancreatic beta-cells: from generation to regeneration. Seminars in Cell and Developmental Biology 21, 838-844
60Yi, F., Liu, G.H. and Izpisua Belmonte, J.C. (2012) Rejuvenating liver and pancreas through cell transdifferentiation. Cell Research 22, 616-619
61Ferber, S. et al. (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nature Medicine 6, 568-572
62Ferber, S. (2000) Can we create new organs from our own tissues? Israel Medical Association Journal 2(Suppl), 32-36
63Ber, I. et al. (2003) Functional, persistent, and extended liver to pancreas transdifferentiation. Journal of Biological Chemistry 278, 31950-31957
64Shternhall-Ron, K. et al. (2007) Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. Journal of Autoimmunity 28, 134-142
65Kaneto, H. et al. (2007) Role of PDX-1 and MafA as a potential therapeutic target for diabetes. Diabetes Research and Clinical Practice 77(Suppl 1), S127-S137
66Tang, D.Q. et al. (2006) Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation. Laboratory Investigation 86, 829-841
67Wang, A.Y. et al. (2007) Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver. Molecular Therapy 15, 255-263
68Sapir, T. et al. (2005) Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proceedings of the National Academy of Sciences of the United States of America 102, 7964-7969
69Baeyens, L. and Bouwens, L. (2008) Can beta-cells be derived from exocrine pancreas? Diabetes, Obesity and Metabolism 10(Suppl 4), 170-178
70Zhou, Q. et al. (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632
71Mauda-Havakuk, M. et al. (2011) Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PLoS One 6, e26298
72Swales, N. et al. (2012) Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS One 7, e37055
Roth, J et al. (2012) Insulin's discovery: new insights on its ninetieth birthday. Diabetes Metabolism Research and Reviews 28, 293-304
US National Diabetes Fact Sheet 2011 can be found at website. The data is generated from Centers for Disease Control and Prevention (CDC), the Indian Health Service's (IHS) National Patient Information Reporting System (NPIRS), the US. Renal Data System of the National Institutes of Health (NIH), the US. Census Bureau, and published studies.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed